All News

A cancer survivor describes how frustrating it can be to experience toxic positivity.

Agent Orange exposure impacted millions of U.S. military personnel during the Vietnam War. The chemical may have led to bladder cancer diagnoses later in life.

African American women with benign ethnic neutropenia had clinical benefit with Ibrance (palbociclib) in combination with endocrine therapy to treat advanced breast cancer.

"Whereas scientific and organizational developments have been landmarks for Dr. Hirsch, his care for patients has always been in the center and, as a cancer survivor himself, he will always have patient care at the forefront."

Topical treatments may lead to little to no scarring in patients with surface-level skin cancer, but patient characteristics, time of year, tumor characteristics and cost determine course of action.

A caregiver explains how she and her daughter soaked up as much joy as possible during the few hours her daughter felt close to normal after breast cancer treatment.

Pap tests should be replaced by more accurate HPV DNA tests, the organization says.

A doctor describes a nurse that he recruited for his own practice while she was receiving treatment for breast cancer.

A patient with lung cancer details her experience with her certified registered nurse practitioner who has been her guiding light even when she feels guilty about smoking for so long.

There is no need for concern of breast cancer for women using fertility drugs to become pregnant, according to recent research.

As rates of merkel cell carcinoma increase, patients should be aware of the risk factors and symptoms of this skin cancer.

The combination may offer patients with recurrent, platinum-agnostic ovarian cancer a more effective, non-platinum-based treatment option.

Keytruda plus gemcitabine and higher doses of radiotherapy showed promising efficacy and safety results in patients with muscle-invasive bladder cancer.

A clinical office practice nurse embraces the positive with her patients and strives for improved outcomes, even when it may not seem possible.

"Although Carolyn loved her role as a navigator, she realized she could help patients with lung cancer with a screening program to help with earlier detection."

The Food and Drug Administration granted a breakthrough therapy designation to a new drug that can be used to treat patients with mantle cell lymphoma.

A woman who underwent surgery for breast cancer shares a transformative experience in which she posed for a photographer who documented her mastectomy scars.

From Ina Jaffe’s breast cancer news to a couple moving up their wedding due to a cancer diagnosis, here’s what’s happening in the cancer landscape this week.

After a 13-year follow-up, researchers found an association between aspirin and ibuprofen use and distal adenoma, recurrent adenoma and colorectal cancer.

After a previous diagnosis of skin cancer, patients are more likely to develop skin cancer lesions on the body. An expert gives helpful tips on what to look for and how to look for lesions to catch them early.

A cancer survivor shares tips for getting through dreaded follow-up appointments that may lead to anxiety.

Will patients be given a placebo? Are clinical trials safe? An expert answers these questions and more.

Donald Rumsfeld, who died from multiple myeloma, served as secretary of defense under Presidents Gerald R. Ford and George W. Bush.

A patient wrote about his oncology nurse when receiving chemotherapy, whose personality helped him look forward to his sessions.

The FDA approval provides patients with an alternative therapy to the only other approved treatment, which has been under a global shortage for several years.

Patients with basal cell or cutaneous squamous cell carcinoma tend to have good outcomes when the disease is caught early. For those in later stages, new treatments bring hope and better prognoses.

According to an expert from The University of Texas MD Anderson Cancer Center, patient enrollment in clinical trials that involve genomic testing are important in progressing research in their cancer types.

A cancer survivor recalls the scary moment she experienced what she thought was a new life-threatening side effect.

Recent research found that women with a history of pregnancy – even if it was not carried to term – had a decreased risk of ovarian cancer.

Patients who tested positive for the biomarker circulating tumor DNA (ctDNA) had improved disease-free and overall survival after receiving Tecentriq.